Synthomer plc (LON:SYNT - Get Free Report) insider Uwe Halder acquired 25,000 shares of Synthomer stock in a transaction that occurred on Thursday, August 7th. The stock was purchased at an average cost of GBX 64 ($0.86) per share, with a total value of £16,000 ($21,511.16).
Synthomer Stock Down 1.7%
Shares of LON:SYNT opened at GBX 61.50 ($0.83) on Monday. The company has a quick ratio of 0.97, a current ratio of 1.90 and a debt-to-equity ratio of 78.27. The business has a fifty day moving average of GBX 98.97 and a two-hundred day moving average of GBX 108.90. The stock has a market cap of £100.85 million, a P/E ratio of -1.23, a PEG ratio of -0.17 and a beta of 1.79. Synthomer plc has a 52-week low of GBX 61 ($0.82) and a 52-week high of GBX 266 ($3.58).
Synthomer (LON:SYNT - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported GBX (5.40) (($0.07)) earnings per share (EPS) for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. On average, research analysts expect that Synthomer plc will post 12.962963 earnings per share for the current year.
Analyst Ratings Changes
SYNT has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft reduced their price objective on Synthomer from GBX 140 ($1.88) to GBX 115 ($1.55) and set a "hold" rating for the company in a research note on Wednesday, July 30th. Jefferies Financial Group restated a "hold" rating and issued a GBX 100 ($1.34) target price on shares of Synthomer in a report on Tuesday, August 5th. Finally, Berenberg Bank dropped their target price on Synthomer from GBX 120 ($1.61) to GBX 80 ($1.08) and set a "hold" rating for the company in a report on Wednesday, August 6th.
Read Our Latest Analysis on Synthomer
Synthomer Company Profile
(
Get Free Report)
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.